Peptide and Protein Delivery with Cell-penetrating Peptides

Peptide and Protein Delivery

Volumn , Issue , 2011, Pages 221-246

  Räägel, Helin ^a   Pooga, Margus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882561630     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384935-9.10010-0     Document Type: Chapter

References (137)

1. V.V. Didenko, H. Ngo and D.S. Baskin (2005) Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies. Anal. Biochem. 344 168-173.
2. J. Futami, M. Kitazoe, T. Maeda, E. Nukui, M. Sakaguchi, J. Kosaka, et al. (2005) Intracellular delivery of proteins into mammalian living cells by polyethylenimine-cationization. J. Biosci. Bioeng. 99 95-103.
3. M. Kitazoe, H. Murata, J. Futami, T. Maeda, M. Sakaguchi, M. Miyazaki, et al. (2005) Protein transduction assisted by polyethylenimine-cationized carrier proteins. J. Biochem. 137 693-701.
4. A. Chonn and P.R. Cullis (1995) Recent advances in liposomal drug-delivery systems. Curr. Opin. Biotechnol. 6 698-708.
5. O. Zelphati, Y. Wang, S. Kitada, J.C. Reed, P.L. Felgner and J. Corbeil (2001) Intracellular delivery of proteins with a new lipid-mediated delivery system. J. Biol. Chem. 276 35103-35110.
6. S. Boeckle and E. Wagner (2006) Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J. 8 E731-E742.
7. L.H. Raptis, H.L. Brownell, S.K. Liu, K.L. Firth, L.W. MacKenzie, C.D. Stiles, et al. (1995) Applications of electroporation of adherent cells in situ, on a partly conductive slide. Mol. Biotechnol. 4 129-138.
8. A.A. Deora, F. Diaz, R. Schreiner and E. Rodriguez-Boulan (2007) Efficient electroporation of DNA and protein into confluent and differentiated epithelial cells in culture. Traffic 8 1304-1312.
9. B.D. Wright, M. Terasaki and J.M. Scholey (1993) Roles of kinesin and kinesin-like proteins in sea urchin embryonic cell division: Evaluation using antibody microinjection. J. Cell Biol. 123 681-689.
10. C. Lappe-Siefke, C. Maas and M. Kneussel (2008) Microinjection into cultured hippocampal neurons: A straightforward approach for controlled cellular delivery of nucleic acids, peptides and antibodies. J. Neurosci. Methods 175 88-95.
11. B.G. Harvey, N.R. Hackett, T. El-Sawy, T.K. Rosengart, E.A. Hirschowitz, M.D. Lieberman, et al. (1999) Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 73 6729-6742.
12. D.A. Muruve (2004) The innate immune response to adenovirus vectors. Hum. Gene Ther. 15 1157-1166.
13. A.D. Frankel and C.O. Pabo (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 1189-1193.
14. M. Green and P.M. Loewenstein (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 1179-1188.
15. E. Vivés, P. Brodin and B. Lebleu (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 16010-16017.
16. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman and J.B. Rothbard (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97 13003-13008.
17. P.E. Thorén, D. Persson, P. Isakson, M. Goksör, A. Önfelt and B. Nordén (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307 100-107.
18. D. Derossi, A.H. Joliot, G. Chassaing and A. Prochiantz (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 10444-10450.
19. G. Elliott and P. O'Hare (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 223-233.
20. A. Elmquist, M. Lindgren, T. Bartfai and Ü Langel (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell. Res. 269 237-244.
21. M. Pooga, M. Hällbrink, M. Zorko and Ü Langel (1998) Cell penetration by transportan. FASEB J. 12 67-77.
22. U. Soomets, M. Lindgren, X. Gallet, M. Hällbrink, A. Elmquist, L. Balaspiri, et al. (2000) Deletion analogues of transportan. Biochim. Biophys. Acta 1467 165-176.
23. M.C. Morris, J. Depollier, J. Mery, F. Heitz and G. Divita (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19 1173-1176.
24. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman and J.B. Rothbard (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56 318-325.
25. I. Nakase, M. Niwa, T. Takeuchi, K. Sonomura, N. Kawabata, Y. Koike, et al. (2004) Cellular uptake of arginine-rich peptides: Roles for macropinocytosis and actin rearrangement. Mol. Ther. 10 1011-1022.
26. J.D. Lear, Z.R. Wasserman and W.F. DeGrado (1988) Synthetic amphiphilic peptide models for protein ion channels. Science 240 1177-1181.
27. Y. Agawa, S. Lee, S. Ono, H. Aoyagi, M. Ohno, T. Taniguchi, et al. (1991) Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic alpha-helical model peptides of various chain lengths. J. Biol. Chem. 266 20218-20222.
28. V. Steiner, M. Schar, K.O. Bornsen and M. Mutter (1991) Retention behaviour of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. J. Chromatogr. 586 43-50.
29. J. Oehlke, A. Scheller, B. Wiesner, E. Krause, M. Beyermann, E. Klauschenz, et al. (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414 127-139.
30. M. Hällbrink, A. Florén, A. Elmquist, M. Pooga, T. Bartfai and Ü Langel (2001) Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515 101-109.
31. M. Hansen, K. Kilk and Ü Langel (2008) Predicting cell-penetrating peptides. Adv. Drug Deliv. Rev. 60 572-579.
32. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, et al. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91 664-668.
33. S.R. Schwarze, K.A. Hruska and S.F. Dowdy (2000) Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10 290-295.
34. J.S. Wadia and S.F. Dowdy (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13 52-56.
35. P. Säälik, A. Elmquist, M. Hansen, K. Padari, K. Saar, K. Viht, et al. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug. Chem. 15 1246-1253.
36. K. Padari, P. Säälik, M. Hansen, K. Koppel, R. Raid, Ü Langel, et al. (2005) Cell transduction pathways of transportans. Bioconjug. Chem. 16 1399-1410.
37. H. Räägel, P. Säälik, M. Hansen, Ü Langel and M. Pooga (2009) CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway. J. Control. Release 139 108-117.
38. S.T. Henriques, J. Costa and M.A. Castanho (2005) Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry 44 10189-10198.
39. K. Weller, S. Lauber, M. Lerch, A. Renaud, H.P. Merkle and O. Zerbe (2005) Biophysical and biological studies of end-group-modified derivatives of Pep-1. Biochemistry 44 15799-15811.
40. H. Myrberg, M. Lindgren and Ü Langel (2007) Protein delivery by the cell-penetrating peptide YTA2. Bioconjug. Chem. 18 170-174.
41. J.S. Wadia, R.V. Stan and S.F. Dowdy (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 310-315.
42. J.M. Gump, R.K. June and S.F. Dowdy (2010) Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction. J. Biol. Chem. 285 1500-1507.
43. Y. Gitton, L. Tibaldi, E. Dupont, G. Levi and A. Joliot (2009) Efficient CPP-mediated Cre protein delivery to developing and adult CNS tissues. BMC Biotechnol. 9 40.
44. P.A. Shaw, I.R. Catchpole, C.A. Goddard and W.H. Colledge (2008) Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein. Biochemistry 47 1157-1166.
45. A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, et al. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278 34141-34149.
46. J.R. Maiolo, M. Ferrer and E.A. Ottinger (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712 161-172.
47. S. El-Andaloussi, P. Järver, H.J. Johansson and Ü Langel (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: A comparative study. Biochem. J. 407 285-292.
48. G. TÜnnemann, R.M. Martin, S. Haupt, C. Patsch, F. Edenhofer and M.C. Cardoso (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J. 20 1775-1784.
49. H. Räägel, P. Säälik and M. Pooga (2010) Peptide-mediated protein delivery – Which pathways are penetrable? Biochim. Biophys. Acta 1798 2240-2248.
50. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing and A. Prochiantz (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271 18188-18193.
51. M. Pooga, C. Kut, M. Kihlmark, M. Hällbrink, S. Fernaeus, R. Raid, et al. (2001) Cellular translocation of proteins by transportan. FASEB J. 15 1451-1453.
52. K. Kilk, M. Magzoub, M. Pooga, L.E. Eriksson, Ü Langel and A. Gräslund (2001) Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide. Bioconjug. Chem. 12 911-916.
53. M. Lundberg and M. Johansson (2002) Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291 367-371.
54. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, et al. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 585-590.
55. S. Deshayes, S. Gerbal-Chaloin, M.C. Morris, G. Aldrian-Herrada, P. Charnet, G. Divita, et al. (2004) On the mechanism of non-endosomal peptide-mediated cellular delivery of nucleic acids. Biochim. Biophys. Acta 1667 141-147.
56. A. Ziegler (2008) Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv. Drug Deliv. Rev. 60 580-597.
57. H.D. Herce, A.E. Garcia, J. Litt, R.S. Kane, P. Martin, N. Enrique, et al. (2009) Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys. J. 97 1917-1925.
58. K. Cahill (2009) Molecular electroporation and the transduction of oligoarginines. Phys. Biol. 7 16001.
59. S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener and K. Ballmer-Hofer (2003) Antennapedia and HIV transactivator of transcription (TAT) protein transduction domains promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278 35109-35114.
60. C. Marty, C. Meylan, H. Schott, K. Ballmer-Hofer and R.A. Schwendener (2004) Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes. Cell Mol. Life Sci. 61 1785-1794.
61. E. Goncalves, E. Kitas and J. Seelig (2005) Binding of oligoarginine to membrane lipids and heparan sulfate: Structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 44 2692-2702.
62. G.M. Poon and J. Gariepy (2007) Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem. Soc. Trans. 35 788-793.
63. P. Säälik, K. Padari, A. Niinep, A. Lorents, M. Hansen, E. Jokitalo, et al. (2009) Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways. Bioconjug. Chem. 20 877-887.
64. F. Galbiati, B. Razani and M.P. Lisanti (2001) Emerging themes in lipid rafts and caveolae. Cell 106 403-411.
65. H. Lodish, A. Berk, S.L. Zipursky, P. Matsudaira, D. Baltimore and J. Darnell (2000) Molecular Cell Biology. San Francisco, USA: W.H. Freeman and Company
66. I. Nakase, A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K. Hiramoto, et al. (2007) Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 46 492-501.
67. S. Futaki, I. Nakase, A. Tadokoro, T. Takeuchi and A.T. Jones (2007) Arginine-rich peptides and their internalization mechanisms. Biochem. Soc. Trans. 35 784-787.
68. T. Kirchhausen (2009) Imaging endocytic clathrin structures in living cells. Trends Cell Biol. 19 596-605.
69. M. Fotin-Mleczek, S. Welte, O. Mader, F. Duchardt, R. Fischer, H. Hufnagel, et al. (2005) Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. 118 3339-3351.
70. J.E. Heuser and R.G. Anderson (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108 389-400.
71. J. Rinne, B. Albarran, J. Jylhävä, T.O. Ihalainen, P. Kankaanpää, V.P. Hytönen, et al. (2007) Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol. 7 1.
72. I.R. Nabi and P.U. Le (2003) Caveolae/raft-dependent endocytosis. J. Cell Biol. 161 673-677.
73. D.J. Barr, A.G. Ostermeyer-Fay, R.A. Matundan and D.A. Brown (2008) Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells. J. Cell Sci. 121 3155-3166.
74. E.M. Damm, L. Pelkmans, J. Kartenbeck, A. Mezzacasa, T. Kurzchalia and A. Helenius (2005) Clathrin- and caveolin-1-independent endocytosis: Entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168 477-488.
75. A. Ferrari, V. Pellegrini, C. Arcangeli, A. Fittipaldi, M. Giacca and F. Beltram (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8 284-294.
76. G.J. Doherty and H.T. McMahon (2009) Mechanisms of endocytosis. Annu. Rev. Biochem. 78 857-902.
77. J. Chen, G. Li, J. Lu, L. Chen, Y. Huang, H. Wu, et al. (2006) A novel type of PTD, common helix-loop-helix motif, could efficiently mediate protein transduction into mammalian cells. Biochem. Biophys. Res. Commun. 347 931-940.
78. S. Kameyama, M. Horie, T. Kikuchi, T. Omura, A. Tadokoro, T. Takeuchi, et al. (2007) Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates. Biopolymers 88 98-107.
79. Y.W. Hou, M.H. Chan, H.R. Hsu, B.R. Liu, C.P. Chen, H.H. Chen, et al. (2007) Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides. Exp. Dermatol. 16 999-1006.
80. S. Gerbal-Chaloin, C. Gondeau, G. Aldrian-Herrada, F. Heitz, C. Gauthier-Rouviere and G. Divita (2007) First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling. Biol. Cell 99 223-238.
81. R. Lundmark, G.J. Doherty, M.T. Howes, K. Cortese, Y. Vallis, R.G. Parton, et al. (2008) The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr. Biol. 18 1802-1808.
82. G.J. Doherty and R. Lundmark (2009) GRAF1-dependent endocytosis. Biochem. Soc. Trans. 37 1061-1065.
83. S. Sabharanjak, P. Sharma, R.G. Parton and S. Mayor (2002) GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2 411-423.
84. P. Bhagatji, R. Leventis, J. Comeau, M. Refaei and J.R. Silvius (2009) Steric and not structure-specific factors dictate the endocytic mechanism of glycosylphosphatidylinositol-anchored proteins. J. Cell Biol. 186 615-628.
85. B. Nichols (2009) Endocytosis of lipid-anchored proteins: Excluding GEECs from the crowd. J. Cell Biol. 186 457-459.
86. M. Kirkham, A. Fujita, R. Chadda, S.J. Nixon, T.V. Kurzchalia, D.K. Sharma, et al. (2005) Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168 465-476.
87. C.A. Stuermer, D.M. Lang, F. Kirsch, M. Wiechers, S.O. Deininger and H. Plattner (2001) Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol. Biol. Cell 12 3031-3045.
88. O.O. Glebov, N.A. Bright and B.J. Nichols (2006) Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell. Biol. 8 46-54.
89. K. Melikov and L.V. Chernomordik (2005) Arginine-rich cell penetrating peptides: From endosomal uptake to nuclear delivery. Cell Mol. Life Sci. 62 2739-2749.
90. C. Lamaze and S.L. Schmid (1995) The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7 573-580.
91. T.D. Pollard, W.C. Earnshaw and J. Lippincott-Schwartz (2008) Cell Biology. USA: Saunders Elsevier
92. R. Misaki, T. Nakagawa, M. Fukuda, N. Taniguchi and T. Taguchi (2007) Spatial segregation of degradation- and recycling-trafficking pathways in COS-1 cells. Biochem. Biophys. Res. Commun. 360 580-585.
93. S. Al-Taei, N.A. Penning, J.C. Simpson, S. Futaki, T. Takeuchi, I. Nakase, et al. (2006) Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjug. Chem. 17 90-100.
94. S.D. Laufer and T. Restle (2008) Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: Quantitative evaluation of overall efficacy employing easy to handle reporter systems. Curr. Pharm. Des. 14 3637-3655.
95. T.B. Potocky, A.K. Menon and S.H. Gellman (2003) Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278 50188-50194.
96. N.J. Caron, S.P. Quenneville and J.P. Tremblay (2004) Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 319 12-20.
97. B. Groner (2009) Peptides as Drugs: Discovery and Development. Wiley-VCH Verlag GmbH & Co
98. L. Pelkmans, J. Kartenbeck and A. Helenius (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3 473-483.
99. K. Padari, K. Koppel, A. Lorents, M. Hällbrink, M. Mano, M.C. Pedroso de Lima, et al. (2010) S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells. Bioconjug. Chem. 21 774-783.
100. S.M. Fuchs and R.T. Raines (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry 43 2438-2444.
101. H. Michiue, K. Tomizawa, F.Y. Wei, M. Matsushita, Y.F. Lu, T. Ichikawa, et al. (2005) The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J. Biol. Chem. 280 8285-8289.
102. Y.J. Lee, A. Erazo-Oliveras and J.P. Pellois (2010) Delivery of macromolecules into live cells by simple co-incubation with a peptide. Chem. Bio. Chem. 11 325-330.
103. A. El-Sayed, S. Futaki and H. Harashima (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment. AAPS J. 11 13-22.
104. S.J. Kwon, K. Han, S. Jung, J.E. Lee, S. Park, Y.P. Cheon, et al. (2009) Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway. BMC Biotechnol. 9 73.
105. R. Fischer, K. Köhler, M. Fotin–Mleczek and R. Brock (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279 12625-12635.
106. S.A. Ezhevsky, A. Ho, M. Becker-Hapak, P.K. Davis and S.F. Dowdy (2001) Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol. Cell Biol. 21 4773-4784.
107. G. Selivanova, V. Iotsova, I. Okan, M. Fritsche, M. Ström, B. Groner, et al. (1997) Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med. 3 632-638.
108. M. Bonfanti, S. Taverna, M. Salmona, M. D'Incalci and M. Broggini (1997) p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res. 57 1442-1446.
109. E.P. Holinger, T. Chittenden and R.J. Lutz (1999) Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274 13298-13304.
110. S.R. Schwarze, A. Ho, A. Vocero-Akbani and S.F. Dowdy (1999) In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285 1569-1572.
111. S.R. Cai, G. Xu, M. Becker-Hapak, M. Ma, S.F. Dowdy and H.L. McLeod (2006) The kinetics and tissue distribution of protein transduction in mice. Eur. J. Pharm. Sci. 27 311-319.
112. H.J. Lee and W.M. Pardridge (2001) Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug. Chem. 12 995-999.
113. Y. Lei, H. Tang, L. Yao, R. Yu, M. Feng and B. Zou (2008) Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. Bioconjug. Chem. 19 421-427.
114. K. Inagaki, L. Chen, F. Ikeno, F.H. Lee, K.I. Imahashi, D.M. Bouley, et al. (2003) Inhibition of delta-protein kinase c protects against reperfusion injury of the ischemic heart in vivo. Circulation 108 2304-2307.
115. B. Cornelissen, K. McLarty, V. Kersemans, D.A. Scollard and R.M. Reilly (2008) Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection. Nucl. Med. Biol. 35 101-110.
116. C.T. McCusker, Y. Wang, J. Shan, M.W. Kinyanjui, A. Villeneuve, H. Michael, et al. (2007) Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J. Immunol. 179 2556-2564.
117. J.M. Choi, M.H. Ahn, W.J. Chae, Y.G. Jung, J.C. Park, H.M. Song, et al. (2006) Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat. Med. 12 574-579.
118. L.H. Jin, J.H. Bahn, W.S. Eum, H.Y. Kwon, S.H. Jang, K.H. Han, et al. (2001) Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic. Biol. Med. 31 1509-1519.
119. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, O.M. Girard, et al. (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16 510-520.
120. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, et al. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328 1031-1035.
121. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings and R.Y. Tsien (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. U.S.A. 101 17867-17872.
122. E.S. Olson, T.A. Aguilera, T. Jiang, L.G. Ellies, Q.T. Nguyen, E.H. Wong, et al. (2009) In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr. Biol. 1 382-393.
123. J.R. MacDougall and L.M. Matrisian (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14 351-362.
124. E.S. Olson, T. Jiang, T.A. Aguilera, Q.T. Nguyen, L.G. Ellies, M. Scadeng, et al. (2010) Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl. Acad. Sci. U.S.A. 107 4311-4316.
125. Q.T. Nguyen, E.S. Olson, T.A. Aguilera, T. Jiang, M. Scadeng, L.G. Ellies, et al. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc. Natl. Acad. Sci. U.S.A. 107 4317-4322.
126. M. Aarts, Y. Liu, L. Liu, S. Besshoh, M. Arundine, J.W. Gurd, et al. (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298 846-850.
127. A. Elmquist and Ü Langel (2003) In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 384 387-393.
128. D.S. Youngblood, S.A. Hatlevig, J.N. Hassinger, P.L. Iversen and H.M. Moulton (2007) Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem. 18 50-60.
129. C. Bonny, A. Oberson, S. Negri, C. Sauser and D.F. Schorderet (2001) Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death. Diabetes 50 77-82.
130. G. TÜnnemann, G. Ter-Avetisyan, R.M. Martin, M. Stockl, A. Herrmann and M.C. Cardoso (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14 469-476.
131. H. Sakurai, K. Kawabata, F. Sakurai, S. Nakagawa and H. Mizuguchi (2008) Innate immune response induced by gene delivery vectors. Int. J. Pharm. 354 9-15.
132. E.L. Snyder and S.F. Dowdy (2004) Cell penetrating peptides in drug delivery. Pharm. Res. 21 389-393.
133. P.G. Frank, S. Pavlides and M.P. Lisanti (2009) Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res. 335 41-47.
134. M. Pooga, U. Soomets, M. Hällbrink, A. Valkna, K. Saar, K. Rezaei, et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16 857-861.
135. F. Nagel, B.H. Falkenburger, L. Tonges, S. Kowsky, C. Poppelmeyer, J.B. Schulz, et al. (2008) Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. J. Neurochem. 105 853-864.
136. T.R. Doeppner, F. Nagel, G.P. Dietz, J. Weise, L. Tonges, S. Schwarting, et al. (2009) TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 29 1187-1196.
137. T.R. Doeppner, G.P. Dietz, M. El Aanbouri, J. Gerber, O.W. Witte, M. Bähr, et al. (2009) TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia. Neurobiol. Dis. 34 87-94.